Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

CHLOASMA, ORAL CONTRACEPTIVES, AND PLASMA IMMUNOREACTIVE β-MELANOCYTE-STIMULATING HORMONE

1977; Elsevier BV; Volume: 68; Issue: 4 Linguagem: Inglês

10.1111/1523-1747.ep12492633

ISSN

1523-1747

Autores

A G Smith, Sam Shuster, A. J. Thody, Mary Anne Peberdy,

Tópico(s)

Dermatologic Treatments and Research

Resumo

Plasma immunoreactive beta-melanocyte stimulating hormone (beta-MSH) has been measured in patients taking a progestogen-only oral contraceptive and in patients taking combined estrogen-progestogen therapy, of whom some had chloasma. Plasma levels did not differ significantly from those in a group of age- and sex-matched controls. It is concluded that the pigmentation of chloasma is not due to increased plasma concentrations of immunoreactive beta-MSH.

Referência(s)